ArticleTranslational psychiatry2026
Developmental trajectories of glutamate and the variable clinical course of ADHD in youth.
Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Recent evidence suggests the brain's major excitatory neurotransmitter, glutamate, plays a key role in attention-deficit/hyperactivity disorder (ADHD). Here we ask if glutamate also plays a role in the variable clinical courses of ADHD. While some children 'grow out' of ADHD by adolescence, others experience persistent symptoms into adulthood. Prior work implicates structural and functional differences in medial prefrontal cortex as pivotal in these different ADHD symptom courses, and we now ask if glutamate developmental change also contributes. Given the role of glutamate in neurotransmission, we also investigate potential impacts on the brain's intrinsic connectivity. Using a glutamate-specific magnetic resonance spectroscopy sequence at 3 T, we analyzed 241 spectra on 161 participants, including 69 with persistent ADHD, 20 with remitting ADHD, and 72 never affected controls. Intrinsic functional connectivity was also assessed in a subset of 104 participants with 141 functional MRI scans. Using linear mixed models, we found an age-related increase in medial prefrontal glutamate in the persistent ADHD group which differed significantly from an age-related decrease among those who remitted and the never affected controls. Furthermore, altered prefrontal glutamate concentrations were associated with changes in intrinsic connectivity between the default mode network (which includes medial frontal cortex) and subcortical regions. These findings may indicate altered maturation of glutamate in the medial prefrontal cortex in youth with persistent ADHD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.